During an official visit to China, Prime Minister Muhammad Shehbaz Sharif met senior executives of Xiuzheng Pharmaceuticals in Hangzhou to discuss expanding Pakistan's pharmaceutical manufacturing capacity, deepening healthcare cooperation, and attracting investment into the country’s growing medical sector. The discussions covered potential increases in Chinese investment, the establishment of new manufacturing facilities, and the expansion of existing plants in Pakistan, alongside topics like technology transfer, supply chains, and regulatory alignment. The Prime Minister highlighted the government’s policies to ease doing business and other investment-friendly steps, emphasizing the importance of business-to-business cooperation between Pakistani and Chinese companies to strengthen Pakistan-China ties. Opinion: If these talks yield tangible commitments and credible implementation, they could accelerate Pakistan’s self-reliance in essential medicines, create jobs, and spur related industries. However, success will depend on transparent agreements, robust governance, predictable regulatory pathways, and safeguards to prevent excessive reliance on a single partner. The Hangzhou meeting signals a pragmatic approach to diversify Pakistan’s economic partnerships and leverage China’s manufacturing strength, but the real test will be delivery, oversight, and ensuring that healthcare needs remain the priority of the investment agenda.
Source: Statement from @GovtofPakistan
Public Engagement: 1,470 views • 12 likes • 2 comments • 3 shares
Published: May 24, 2026, 11:42 am
Editorial Note: This article is based on publicly available information and official statements. We strives for accuracy and fairness in all reporting.
{comments}
